Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
What Factors Will Drive Pfizer's Q1 Performance?
01:00pm, Friday, 26'th Apr 2024
Pfizer (NYSE: PFE) is scheduled to report its Q1 2024 results on Wednesday, May 1. We expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
10:21am, Friday, 26'th Apr 2024
Beyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
Pfizer Receives FDA Approval for Bleeding Disorder Treatment
09:35am, Friday, 26'th Apr 2024
The treatment, Beqvez, will be available by prescription to eligible patients this quarter.
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
07:45am, Friday, 26'th Apr 2024
Pfizer, Bank of Nova Scotia, and AT&T all offer high yields of at least 6.5%. These stocks not only offer high payouts, they also have long-term potential.
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
07:02am, Friday, 26'th Apr 2024
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
3 Bargain Stocks Near 52-week Lows
09:46am, Thursday, 25'th Apr 2024
Markets were scared to wake up to the Federal Reserve (the Fed) pulling the rug. After pricing in the proposed interest rate cuts for 2024, which were set to be implemented by March, then May, and now
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
09:40am, Thursday, 25'th Apr 2024
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-1
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
01:06pm, Wednesday, 24'th Apr 2024
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline
6 of the Highest-Yielding S&P 500 Stocks Offer Huge Passive Income
07:30am, Wednesday, 24'th Apr 2024
A financial advisor can help you understand the advantages and disadvantages of investment properties.
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
07:25am, Wednesday, 24'th Apr 2024
In the changing environment of 2024, astute investors have a plethora of options to strengthen their financial portfolios strategically by purchasing dividend stocks. These prospects result from i
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
03:00pm, Tuesday, 23'rd Apr 2024
Big money tends to flow from one sector to the other. During the pandemic, sectors like pharmaceutical and e-commerce were hot.
Better Buy: Pfizer vs. Viking Therapeutics
09:15am, Tuesday, 23'rd Apr 2024
Shares of Pfizer and Viking Therapeutics have been on markedly different trajectories over the prior three years. In this comparison, Pfizer scans as a safer choice for cautious investors, while Vikin
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
07:21am, Tuesday, 23'rd Apr 2024
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday.
Pfizer (PFE) Rises Higher Than Market: Key Facts
06:51pm, Monday, 22'nd Apr 2024
Pfizer (PFE) reachead $26.26 at the closing of the latest trading day, reflecting a +1% change compared to its last close.
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
05:44pm, Monday, 22'nd Apr 2024
It's an established point that blue-chip stocks are an essential part of the portfolio. The exposure to blue-chips can differ based on the risk-taking ability of an investor.
